Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble melatonin tripartate adduct for the prevention and treatment of rare and severe eye sight-threatening conditions and neuro-ophthalmic disorders

Soluble melatonin tripartate adduct for the prevention and treatment of rare and severe eye sight-threatening conditions and neuro-ophthalmic disorders

US Patent 11684623 · Granted Jun 27, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anhydrous liquid melatonin composition2019
Anhydrous liquid melatonin composition2019
Machine for neutralizing the bacterial content of hospital waste or other specia2016
Sialochimeric compounds2016
Sialochimeric compounds2016
Antiviral compounds2012
Antiviral compounds2012
Plasma generator2009
Use of modified lysozyme C to prepare medicinal compositions for the treatment o2006
Allomorph of isomer Z hydrochloride of alkylaminofurane derivative2005
Programmed release ambroxol--HCl dosage forms2001
Calcitonin salmon analogues2000